In breast cancer, P-cad is overexpressed in a molecular subset of highly aggressive basal-like triple-negative carcinomas, being significantly associated with worse disease-free and overall patient survival (Paredes et al., 2005). The gene discussed is CDH3; the disease is breast carcinoma.